Omni 360 Wealth, Inc. Ironwood Pharmaceuticals Inc Transaction History
Omni 360 Wealth, Inc.
- $203 Billion
- Q2 2025
A detailed history of Omni 360 Wealth, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Omni 360 Wealth, Inc. holds 18,680 shares of IRWD stock, worth $28,954. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,680Holding current value
$28,954% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
176Shares Held
160MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$35.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$25.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$25 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$24.7 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$13 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $238M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...